Vertex Pharmaceuticals (VRTX) Insider Trading & Ownership $392.05 +2.97 (+0.76%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$393.20 +1.15 (+0.29%) As of 08/28/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Vertex Pharmaceuticals (NASDAQ:VRTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.20%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.95MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$4.36M Get VRTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vertex Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VRTX Insider Buying and Selling by Quarter Vertex Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/6/2025Bruce I SachsDirectorBuy5,000$389.68$1,948,400.00 6/11/2025Lisa C. McClainU.S. Congress Member (R-MI)Sell$452.44$1,001 - $15,0006/10/2025Lisa C. McClainU.S. Congress Member (R-MI)Sell$451.52$1,001 - $15,0005/15/2025David AltshulerEVPSell52$424.69$22,083.88 5/12/2025Jefferson ShreveU.S. Congress Member (R-IN)Sell$439.37$15,001 - $50,0003/20/2025Byron DonaldsU.S. Congress Member (R-FL)Sell$510.18$1,001 - $15,0003/13/2025Jefferson ShreveU.S. Congress Member (R-IN)Buy$502.92$15,001 - $50,0003/10/2025David AltshulerEVPSell3,231$500.00$1,615,500.00 2/27/2025Ourania TatsisEVPSell530$475.34$251,930.20 2/24/2025Jefferson ShreveU.S. Congress Member (R-IN)Buy$481.65$15,001 - $50,0002/18/2025Ourania TatsisEVPSell244$455.06$111,034.64 2/11/2025Ourania TatsisEVPSell310$459.83$142,547.30 11/15/2024David AltshulerEVPSell15$478.56$7,178.40 8/30/2024Jeffrey M LeidenChairmanSell3,784$499.00$1,888,216.00 8/30/2024Sangeeta N BhatiaDirectorSell646$500.00$323,000.00 (Data available from 1/1/2013 forward) VRTX Insider Trading Activity - Frequently Asked Questions Who is on Vertex Pharmaceuticals' Insider Roster? The list of insiders at Vertex Pharmaceuticals includes Amit Sachdev, Bastiano Sanna, Bruce I Sachs, Carmen Bozic, Charles F Wagner Jr, David Altshuler, Edward Morrow Atkinson III, Jeffrey M Leiden, Jonathan Biller, Kristen Ambrose, Lloyd Carney, Ourania Tatsis, Reshma Kewalramani, Sangeeta N Bhatia, Stuart A Arbuckle, and Yuchun Lee. Learn more on insiders at VRTX. What percentage of Vertex Pharmaceuticals stock is owned by insiders? 0.20% of Vertex Pharmaceuticals stock is owned by insiders. Learn more on VRTX's insider holdings. Which Vertex Pharmaceuticals insiders have been buying company stock? The following insider purchased VRTX shares in the last 24 months: Bruce I Sachs ($1,948,400.00). How much insider buying is happening at Vertex Pharmaceuticals? Insiders have purchased a total of 5,000 VRTX shares in the last 24 months for a total of $1,948,400.00 bought. Which Vertex Pharmaceuticals insiders have been selling company stock? The following insiders have sold VRTX shares in the last 24 months: Amit Sachdev ($1,354,013.28), Bruce I Sachs ($10,189,814.00), Carmen Bozic ($14,548,270.35), Charles F Wagner Jr ($1,478,067.50), David Altshuler ($1,644,762.28), Edward Morrow Atkinson III ($3,483,664.00), Jeffrey M Leiden ($10,636,199.92), Jonathan Biller ($211,523.60), Kristen Ambrose ($577,409.76), Ourania Tatsis ($1,890,097.64), Reshma Kewalramani ($8,270,599.00), Sangeeta N Bhatia ($501,245.00), and Stuart A Arbuckle ($1,804,930.80). How much insider selling is happening at Vertex Pharmaceuticals? Insiders have sold a total of 131,455 Vertex Pharmaceuticals shares in the last 24 months for a total of $56,590,597.13 sold. Which members of congress are trading Vertex Pharmaceuticals? Jefferson Shreve (R-IN) has bought shares of Vertex Pharmaceuticals in the last year totaling $65,000. Lisa C. McClain (R-MI), Jefferson Shreve (R-IN), and Byron Donalds (R-FL) have sold shares totaling $56,500. Vertex Pharmaceuticals Key ExecutivesDr. Jeffrey Marc Leiden M.D. (Age 68)Ph.D., Executive Chairman Compensation: $95.02kDr. Reshma Kewalramani FASN (Age 51)M.D., CEO, President & Director Compensation: $5.59MMr. Charles F. Wagner Jr. (Age 56)Executive VP & CFO Compensation: $2.12MMr. Stuart A. Arbuckle B.Sc. (Age 58)Executive VP & COO Compensation: $2.76MDr. David M. Altshuler M.D. (Age 59)Ph.D., Executive VP & Chief Scientific Officer Compensation: $2.17MMs. Kristen C. Ambrose CPA (Age 47)Senior VP & Chief Accounting Officer Mr. Mike TirozziSVP and Chief Information & Data OfficerSusie LisaSenior Vice President of Investor RelationsMr. Jonathan Biller J.D. (Age 60)Executive VP & Chief Legal Officer Ms. Nina DevlinSenior VP & Chief Communications Officer More Insider Trading Tools from MarketBeat Related Companies Amazon.com Insider Selling Axsome Therapeutics Insider Selling CRISPR Therapeutics Insider Selling Editas Medicine Insider Selling Alphabet Insider Selling Intuitive Surgical Insider Selling Moderna Insider Selling AbbVie Insider Selling Eli Lilly and Company Insider Selling Pfizer Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NASDAQ:VRTX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.